Valuation: Camurus AB

Market Cap 37.4B 3.88B 3.39B 3.13B 2.88B 5.44B 374B 5.56B 14.71B 183B 14.57B 14.25B 630B P/E 2026 *
39.4x
P/E 2027 * 25.4x
Enterprise Value 32.84B 3.41B 2.98B 2.75B 2.53B 4.77B 328B 4.88B 12.92B 161B 12.79B 12.51B 553B EV / Sales 2026 *
11.5x
EV / Sales 2027 * 8.34x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-1.64%
1 week+13.35%
Current month+11.14%
1 month+17.92%
3 months+8.55%
6 months-9.11%
Current year+2.03%
1 week 525.5
Extreme 525.5
645
1 month 505
Extreme 505
645
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
754.5
3 years 279.2
Extreme 279.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap.
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
27/02/26 Sell

Chief Executive Officer

9,950 0.0166%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
Change 5-day change 1-year change 3-year change Capi.($)
-1.64%+13.35%-9.44%+123.82% 3.88B
+0.85%-0.80%+54.84%+163.70% 1,051B
+1.23%-1.53%+55.26%+59.07% 609B
+0.04%+2.58%+32.96%+88.75% 450B
+0.78%-0.71%+30.04%+24.61% 330B
+1.41%+0.58%+33.92%+47.20% 284B
-0.27%-1.87%+22.13%+23.47% 263B
-1.76%+2.37%-22.19%-38.45% 223B
-1.42%+0.80%+22.81%+60.77% 198B
-1.48%+3.43%+23.42%+73.31% 167B
Average -0.27%+1.82%+24.37%+62.62% 357.89B
Weighted average by Cap. +0.21%+0.04%+37.70%+81.54%

Financials

2026 *2027 *
Net sales 2.85B 295M 258M 238M 220M 414M 28.44B 423M 1.12B 13.93B 1.11B 1.08B 47.95B 3.79B 393M 344M 317M 292M 551M 37.87B 563M 1.49B 18.55B 1.48B 1.44B 63.85B
Net income 968M 100M 87.78M 81M 74.66M 141M 9.67B 144M 381M 4.74B 377M 369M 16.31B 1.45B 151M 132M 122M 112M 211M 14.52B 216M 572M 7.11B 566M 554M 24.48B
Net Debt -4.56B -473M -414M -382M -352M -663M -45.59B -678M -1.79B -22.33B -1.78B -1.74B -76.87B -5.81B -602M -527M -486M -448M -844M -58.02B -863M -2.28B -28.42B -2.26B -2.21B -97.82B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
17/07/26 SEK 628.50 -1.64% 67,377
16/07/26 SEK 639.00 +3.90% 109,880
15/07/26 SEK 615.00 +16.81% 380,833
14/07/26 SEK 526.50 -2.05% 69,616
13/07/26 SEK 537.50 -3.07% 72,062
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
628.50SEK
Average target price
776.75SEK
Spread / Average Target
+23.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock